196 related articles for article (PubMed ID: 31482518)
21. Effect of taste masking technology on fast dissolving oral film: dissolution rate and bioavailability.
Zhu Y; You X; Huang K; Raza F; Lu X; Chen Y; Dhinakar A; Zhang Y; Kang Y; Wu J; Ge L
Nanotechnology; 2018 Jul; 29(30):304001. PubMed ID: 29694333
[TBL] [Abstract][Full Text] [Related]
22. Enhance the dissolution rate and oral bioavailability of pranlukast by preparing nanosuspensions with high-pressure homogenizing method.
Wang L; Hao Y; Liu N; Ma M; Yin Z; Zhang X
Drug Dev Ind Pharm; 2012 Nov; 38(11):1381-9. PubMed ID: 22300415
[TBL] [Abstract][Full Text] [Related]
23. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.
Pu X; Sun J; Wang Y; Wang Y; Liu X; Zhang P; Tang X; Pan W; Han J; He Z
Int J Pharm; 2009 Sep; 379(1):167-73. PubMed ID: 19505545
[TBL] [Abstract][Full Text] [Related]
24. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
[TBL] [Abstract][Full Text] [Related]
25. Spray-dried solid dispersions of nifedipine and vinylcaprolactam/vinylacetate/PEG₆₀₀₀ for compacted oral formulations.
Soulairol I; Tarlier N; Bataille B; Cacciaguerra T; Sharkawi T
Int J Pharm; 2015 Mar; 481(1-2):140-7. PubMed ID: 25579869
[TBL] [Abstract][Full Text] [Related]
26. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.
Mou D; Chen H; Wan J; Xu H; Yang X
Int J Pharm; 2011 Jul; 413(1-2):237-44. PubMed ID: 21540090
[TBL] [Abstract][Full Text] [Related]
27. Development and characterization of an orodispersible film containing drug nanoparticles.
Shen BD; Shen CY; Yuan XD; Bai JX; Lv QY; Xu H; Dai L; Yu C; Han J; Yuan HL
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1348-56. PubMed ID: 24103635
[TBL] [Abstract][Full Text] [Related]
28. Preparation, characterization, stability and in vitro-in vivo evaluation of pellet-layered Simvastatin nanosuspensions.
Luo Y; Xu L; Tao X; Xu M; Feng J; Tang X
Drug Dev Ind Pharm; 2013 Jul; 39(7):936-46. PubMed ID: 23046250
[TBL] [Abstract][Full Text] [Related]
29. Improved Oral Bioavailability of Lacidipine Using Nanosuspension Technology: Inferior in vitro Dissolution and Superior in vivo Drug Absorption versus Lacipil®.
Zhao J; Luo L; Fu Q; Guo B; Li Y; Geng Y; Wang J; Zhang T
Curr Drug Deliv; 2016; 13(5):764-73. PubMed ID: 25963306
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous Determination of Loratadine and Its Metabolite Desloratadine in Beagle Plasma by LC-MS/MS and Application for Pharmacokinetics Study of Loratadine Tablets and Omeprazole‑Induced Drug-Drug Interaction.
Zhang Y; Zhang J; Xu Q; Wang Y; Wu W; Wang W; Li X; Zhang T
Drug Des Devel Ther; 2021; 15():5109-5122. PubMed ID: 34992347
[TBL] [Abstract][Full Text] [Related]
31. Preparation and Optimization of Amorphous Ursodeoxycholic Acid Nano-suspensions by Nanoprecipitation based on Acid-base Neutralization for Enhanced Dissolution.
Xie Y; Chen Z; Su R; Li Y; Qi J; Wu W; Lu Y
Curr Drug Deliv; 2017; 14(4):483-491. PubMed ID: 27593183
[TBL] [Abstract][Full Text] [Related]
32. Etoposide Amorphous Nanopowder for Improved Oral Bioavailability: Formulation Development, Optimization, in vitro and in vivo Evaluation.
Wang Y; Wang S; Xu Y; Wang P; Li S; Liu L; Liu M; Jin X
Int J Nanomedicine; 2020; 15():7601-7613. PubMed ID: 33116490
[TBL] [Abstract][Full Text] [Related]
33. Soluplus(®) based 9-nitrocamptothecin solid dispersion for peroral administration: preparation, characterization, in vitro and in vivo evaluation.
Lian X; Dong J; Zhang J; Teng Y; Lin Q; Fu Y; Gong T
Int J Pharm; 2014 Dec; 477(1-2):399-407. PubMed ID: 25445521
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of freeze-drying drug nanosuspensions.
Chung NO; Lee MK; Lee J
Int J Pharm; 2012 Nov; 437(1-2):42-50. PubMed ID: 22877696
[TBL] [Abstract][Full Text] [Related]
35. Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate.
Qiao H; Chen L; Rui T; Wang J; Chen T; Fu T; Li J; Di L
Int J Nanomedicine; 2017; 12():1033-1046. PubMed ID: 28223797
[TBL] [Abstract][Full Text] [Related]
36. Preparation and solidification of redispersible nanosuspensions.
Zhang X; Guan J; Ni R; Li LC; Mao S
J Pharm Sci; 2014 Jul; 103(7):2166-2176. PubMed ID: 24840928
[TBL] [Abstract][Full Text] [Related]
37. Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition.
Rahim H; Sadiq A; Khan S; Amin F; Ullah R; Shahat AA; Mahmood HM
Int J Nanomedicine; 2019; 14():6287-6296. PubMed ID: 31496686
[TBL] [Abstract][Full Text] [Related]
38. Increase in Dissolution Rate of Zotepine via Nanomilling Process - Impact of Dried Nanocrystalline Suspensions on Bioavailability.
Parmar K; Oza K
AAPS PharmSciTech; 2021 Dec; 23(1):20. PubMed ID: 34907489
[TBL] [Abstract][Full Text] [Related]
39. In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods.
Meng J; Li S; Yao Q; Zhang L; Weng Y; Cai C; Xu H; Tang X
Drug Dev Ind Pharm; 2014 Jul; 40(7):929-36. PubMed ID: 23614872
[TBL] [Abstract][Full Text] [Related]
40. D-Alpha-tocopherol acid polyethylene glycol 1000 succinate, an effective stabilizer during solidification transformation of baicalin nanosuspensions.
Yue PF; Wan J; Wang Y; Li Y; Ma YQ; Yang M; Hu PY; Yuan HL; Wang CH
Int J Pharm; 2013 Feb; 443(1-2):279-87. PubMed ID: 23291447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]